Want to see GB:ICON full AI Analyst Report?
Iconic Labs plc (ICON) AI Stock Analysis
Top Page
Iconic Labs plc
(LSE:ICON)
The score is driven primarily by very weak financial performance (near-zero revenue, recurring operating losses, negative equity, and negative operating/free cash flow), which materially elevates solvency and funding risk. Technicals are also bearish with the price below key moving averages and a negative MACD, despite oversold readings. Valuation provides limited support because the negative P/E reflects losses and dividend yield is unavailable.
Iconic Labs plc (ICON) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- GBP 224.98K
- Dividend Yield
- ―
- Average Volume (3M)
- 181.59K
- Price to Earnings (P/E)
- -0.3
- Beta (1Y)
- 0.20
- Revenue Growth
- ―
- EPS Growth
- 26.98%
- Country
- UK
- Employees
- 3
- Sector
- Communication Services
- Sector Strength
- 60
- Industry
- Advertising Agencies
Iconic Labs plc Business Overview & Revenue Model
Company Description
Iconic Labs Plc functions as a media and technology enterprise, primarily concentrating on digital marketing solutions and developing products powered by content and advanced technology. The company also engages in digital and social media publishing...
Iconic Labs plc Financial Statement Overview
Summary
Very weak fundamentals: revenue has effectively fallen to near-zero in recent years, operating losses persist (negative EBIT across all years shown), equity is negative throughout (solvency risk), and operating/free cash flow is mostly negative, indicating ongoing cash burn and funding pressure.
Income Statement
8Very NegativeBalance Sheet
6Very NegativeCash Flow
10Very Negative| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 26.82K |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 26.24K |
| EBITDA | -475.79K | -475.79K | -555.12K | 4.77M | 52 | -759.60K |
| Net Income | -548.88K | -548.88K | -628.23K | 4.77M | 418.95K | -762.00K |
Balance Sheet | ||||||
| Total Assets | 21.55K | 21.55K | 95.04K | 50.24K | 139.34K | 6 |
| Cash, Cash Equivalents and Short-Term Investments | 4,363 | 4,363 | 35.74K | 50.24K | 129.31K | 5 |
| Total Debt | 3.53M | 3.53M | 3.08M | 1.94M | 2.65M | 2.42M |
| Total Liabilities | 4.50M | 4.50M | 4.06M | 3.69M | 2.86M | 8.94M |
| Stockholders Equity | -4.48M | -4.48M | -3.96M | -3.64M | -2.72M | -8.94M |
Cash Flow | ||||||
| Free Cash Flow | -192.76K | 0 | -448.07K | -919.76K | -802.71K | -50.92K |
| Operating Cash Flow | -446.87K | -446.88K | -448.07K | -919.76K | -802.71K | -50.92K |
| Investing Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 415.50K | 415.50K | 354.50K | 970.00K | 881.78K | 0 |
Iconic Labs plc Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ICON, the sentiment is Negative. The current price of 1.25 is below the 20-day moving average (MA) of 1.54, below the 50-day MA of 1.60, and below the 200-day MA of 1.73, indicating a bearish trend. The MACD of -0.11 indicates Positive momentum. The RSI at 26.31 is Positive, neither overbought nor oversold. The STOCH value of 17.33 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:ICON.
Iconic Labs plc Peers Comparison
Overall Rating
GB:SYS162Neutral
GB:TMG56Neutral
GB:MDZ50Neutral
GB:DNM47Neutral- GB:ICON42Neutral
GB:MIRI40.3Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| GB:SYS1 | 62Neutral | GBP 41.87M | 31.88 | 9.14% | 1.82% | -1.27% | -70.61% |
| Sector * | 60Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |
| GB:TMG | 56Neutral | GBP 24.46M | -1.57 | -26.56% | ― | 13.48% | -495.86% |
| GB:MDZ | 50Neutral | GBP 1.54M | 1.88 | 68.09% | ― | 29.26% | ― |
| GB:DNM | 47Neutral | GBP 19.52M | -27.66 | -10.38% | ― | 2.25% | -158.24% |
| GB:ICON | 42Neutral | GBP 230.19K | -0.34 | 12.60% | ― | ― | 26.98% |
| GB:MIRI | 40Neutral | GBP 409.74K | -0.00 | -148.46% | ― | ― | ― |
* Communication Services Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:ICON | Iconic Labs plc | 1.25 | -1.00 | -44.44% | |
| GB:MDZ | Mediazest plc | 0.07 | -0.03 | -25.00% | |
| GB:TMG | The Mission Group plc | 27.00 | 6.50 | 31.71% | |
| GB:SYS1 | System1 Group plc | 330.00 | 94.30 | 40.01% | |
| GB:MIRI | Mirriad Advertising plc | 0.01 | 0.00 | 0.00% | |
| GB:DNM | Dianomi Plc | 65.00 | 47.50 | 271.43% |
Iconic Labs plc Corporate Events
Iconic Labs Stays in Cash-Shell Limbo as Hunt for RTO Target Continues
NegativeIconic Labs Plc, a former media and technology venture now operating as a cash shell on the London Stock Exchange, is concentrated on acquiring a new business through a reverse takeover after exiting administration. With Gay Star News as its only ass...
Iconic Labs Updates Share Capital and Admits New Stock to LSE Main Market
NeutralIconic Labs PLC is a London-listed company with ordinary shares traded on the Main Market of the London Stock Exchange, providing investors with a single-class equity structure in which each low‑denomination share carries one voting right. The...
Iconic Labs Expands Share Capital Through Convertible Note Conversion
NeutralIconic Labs PLC has received a valid conversion notice for one convertible note, resulting in the issuance of 370,370 new ordinary shares at a conversion price of GBP 0.0135 per share and an aggregate principal amount of £5,000. The new shares a...
Iconic Labs Issues New Shares Following Convertible Note Conversion
NeutralIconic Labs PLC has received a valid notice to convert one of its outstanding convertible notes into equity, resulting in the issue of 420,168 new ordinary shares at a conversion price of GBP 0.0119 for a principal amount of £5,000. The new shar...
Iconic Labs updates total voting rights after new share admissions
NeutralIconic Labs plc has confirmed that its issued share capital now comprises 16,780,647 ordinary shares of £0.0001 each, all carrying one voting right and with no shares held in treasury, establishing the total number of voting rights shareholders...
Iconic Labs Increases Share Capital Following Convertible Note Conversion
NeutralIconic Labs plc has received a valid conversion notice for one of its convertible notes, resulting in the conversion of £5,000 principal into 427,350 new ordinary shares at a price of £0.0117 per share. The new shares, each with a nominal v...
Iconic Labs Confirms Total Voting Rights at 16.4 Million Shares
NeutralIconic Labs PLC has confirmed that, as of 31 July 2026, its issued share capital comprises 16,410,277 Ordinary Shares of £0.0001, each carrying one voting right. The company holds no shares in treasury, so the total number of voting rights fully...
Iconic Labs Boosts Share Capital After Convertible Note Conversion
NeutralIconic Labs PLC, a London-listed company whose ordinary shares represent its voting rights base, operates within the framework of U.K. financial regulation, including the FCA’s transparency regime and the Market Abuse Regulation. Its capital ma...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 28, 2026